Literature DB >> 29453212

Implant of a left atrial appendage occluder device (Watchman) and leadless pacing system (Micra) through the same venous access in a single sitting.

Sofian Johar1, Nazar Luqman1.   

Abstract

A left atrial appendage occluder device (Watchman) and leadless pacemaker (Micra) was implanted from a single right femoral vein access in a 73-year-old female patient with persistent atrial fibrillation and symptomatic tachy-brady syndrome and unable to take oral anticoagulants. Standard methods of implantation were followed for both procedures. The Watchman device was implanted first followed by dilatation of the same venous access site in order to implant Micra transcatheter pacing system. The patient tolerated the procedures well and there were no complications. At the end of 1 month, both the devices were found to be working well. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  interventional cardiology; pacing and electrophysiology

Mesh:

Year:  2018        PMID: 29453212      PMCID: PMC5836603          DOI: 10.1136/bcr-2017-222471

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

1.  A Leadless Intracardiac Transcatheter Pacing System.

Authors:  Dwight Reynolds; Gabor Z Duray; Razali Omar; Kyoko Soejima; Petr Neuzil; Shu Zhang; Calambur Narasimhan; Clemens Steinwender; Josep Brugada; Michael Lloyd; Paul R Roberts; Venkata Sagi; John Hummel; Maria Grazia Bongiorni; Reinoud E Knops; Christopher R Ellis; Charles C Gornick; Matthew A Bernabei; Verla Laager; Kurt Stromberg; Eric R Williams; J Harrison Hudnall; Philippe Ritter
Journal:  N Engl J Med       Date:  2015-11-09       Impact factor: 91.245

2.  2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA).

Authors:  Michele Brignole; Angelo Auricchio; Gonzalo Baron-Esquivias; Pierre Bordachar; Giuseppe Boriani; Ole-A Breithardt; John Cleland; Jean-Claude Deharo; Victoria Delgado; Perry M Elliott; Bulent Gorenek; Carsten W Israel; Christophe Leclercq; Cecilia Linde; Lluís Mont; Luigi Padeletti; Richard Sutton; Panos E Vardas; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Paulus Kirchhof; Carina Blomstrom-Lundqvist; Luigi P Badano; Farid Aliyev; Dietmar Bänsch; Helmut Baumgartner; Walid Bsata; Peter Buser; Philippe Charron; Jean-Claude Daubert; Dan Dobreanu; Svein Faerestrand; David Hasdai; Arno W Hoes; Jean-Yves Le Heuzey; Hercules Mavrakis; Theresa McDonagh; Jose Luis Merino; Mostapha M Nawar; Jens Cosedis Nielsen; Burkert Pieske; Lidija Poposka; Frank Ruschitzka; Michal Tendera; Isabelle C Van Gelder; Carol M Wilson
Journal:  Eur Heart J       Date:  2013-06-24       Impact factor: 29.983

3.  Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial.

Authors:  John W Eikelboom; Lars Wallentin; Stuart J Connolly; Mike Ezekowitz; Jeff S Healey; Jonas Oldgren; Sean Yang; Marco Alings; Scott Kaatz; Stefan H Hohnloser; Hans-Christoph Diener; Maria Grazia Franzosi; Kurt Huber; Paul Reilly; Jeanne Varrone; Salim Yusuf
Journal:  Circulation       Date:  2011-05-16       Impact factor: 29.690

4.  Incidence and predictors of short- and long-term complications in pacemaker therapy: the FOLLOWPACE study.

Authors:  Erik O Udo; Nicolaas P A Zuithoff; Norbert M van Hemel; Carel C de Cock; Thijs Hendriks; Pieter A Doevendans; Karel G M Moons
Journal:  Heart Rhythm       Date:  2011-12-17       Impact factor: 6.343

5.  Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry.

Authors:  Vivek Y Reddy; David Holmes; Shephal K Doshi; Petr Neuzil; Saibal Kar
Journal:  Circulation       Date:  2011-01-17       Impact factor: 29.690

6.  Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial.

Authors:  Vivek Y Reddy; Shephal K Doshi; Horst Sievert; Maurice Buchbinder; Petr Neuzil; Kenneth Huber; Jonathan L Halperin; David Holmes
Journal:  Circulation       Date:  2013-01-16       Impact factor: 29.690

7.  Combined Left Atrial Appendage Closure and Pacemaker Implant through a Single Right Femoral Vein Access.

Authors:  François Regoli; Tiziano Moccetti; Elena Pasotti; Angelo Auricchio; Marco Moccetti
Journal:  Pacing Clin Electrophysiol       Date:  2016-04-13       Impact factor: 1.976

Review 8.  Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation.

Authors:  J L Blackshear; J A Odell
Journal:  Ann Thorac Surg       Date:  1996-02       Impact factor: 4.330

9.  Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.

Authors:  Margaret C Fang; Yuchiao Chang; Elaine M Hylek; Jonathan Rosand; Steven M Greenberg; Alan S Go; Daniel E Singer
Journal:  Ann Intern Med       Date:  2004-11-16       Impact factor: 25.391

10.  Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark.

Authors:  Rikke Esberg Kirkfeldt; Jens Brock Johansen; Ellen Aagaard Nohr; Ole Dan Jørgensen; Jens Cosedis Nielsen
Journal:  Eur Heart J       Date:  2013-12-17       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.